New Frontiers in Heart Health

In this webinar, you will learn:

  • Differentiation and clinical significance of lipid markers
  • Functional pathology approach to understanding biomarkers of CVD
  • Genetic risk factors and markers
  • Understanding a lab report
  • Management options in cholesterol and cardiovascular health

$9.95

Why is this important?

Half of myocardial infarctions occur in patients with no overt hyperlipidaemia, and 20% occur in the absence of any classic risk factor. 50% of people who suffer from coronary artery disease (CAD) have normal cholesterol levels indicates the need for a more specific diagnostic tool.

A New Paradigm in LDL-Subfractions, oxidation of LDL and hereditary markers in Cholesterol Control can elucidate cardiovascular risk. The anti-inflammatory or lipid-lowering effects of pharmacologic and nutritional therapies can further be elucidated with genetic polymorphisms and apo-lipoprotein markers.

Learning Outcomes

In this webinar, you will learn:

  • Differentiation and clinical significance of lipid markers
  • Functional pathology approach to understanding biomarkers of CVD
  • Genetic risk factors and markers
  • Understanding a lab report
  • Management options in cholesterol and cardiovascular health

Video

Video Duration: 38:18mins

This offering provides CPD continuing professional development credits for

CMA